AIDS-defining opportunistic illnesses in US patients, 1994-2007: a cohort study.
about
Interventions for tobacco use cessation in people living with HIV and AIDSInterventions for tobacco use cessation in people living with HIV and AIDSDisparities in the Magnitude of Human Immunodeficiency Virus-related Opportunistic Infections Between High and Low/Middle-income Countries: Is Highly Active Antiretroviral Therapy Changing the Trend?Evaluation of PCR in bronchoalveolar lavage fluid for diagnosis of Pneumocystis jirovecii pneumonia: a bivariate meta-analysis and systematic reviewHIV infection, aging, and immune function: implications for cancer risk and preventionEpidemiology and long-term survival in HIV-infected patients with Pneumocystis jirovecii pneumonia in the HAART era: experience in a university hospital and review of the literaturePneumocystis jirovecii pneumonia in Latin America. A public health problem?Shifting the paradigm: using HIV surveillance data as a foundation for improving HIV care and preventing HIV infection.Progressive multifocal leukoencephalopathy in pediatric patients: case report and literature review.Clinical characteristics and outcomes in 303 HIV-infected patients with invasive fungal infections: data from the Prospective Antifungal Therapy Alliance registry, a multicenter, observational studyThe prevalence of opportunistic infections and malignancies in autopsied patients with human immunodeficiency virus infection in JapanTrends in AIDS-defining opportunistic illnesses incidence over 25 years in Rio de Janeiro, Brazil.A mathematical model of comprehensive test-and-treat services and HIV incidence among men who have sex with men in the United States.Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of thePrevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Updated Guidelines from the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious DiseasEffectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patientsPredictive clinical factors in the diagnosis of gastrointestinal Kaposi's sarcoma and its endoscopic severity.Incidence of WHO stage 3 and 4 conditions following initiation of anti-retroviral therapy in resource limited settings.Paradoxical immune reconstitution inflammatory syndrome in HIV-infected patients treated with combination antiretroviral therapy after AIDS-defining opportunistic infection.AIDS incidence and AIDS-related mortality in British Columbia, Canada, between 1981 and 2013: a retrospective studyBlood (1->3)-beta-D-glucan as a diagnostic test for HIV-related Pneumocystis jirovecii pneumonia.Trends in reported AIDS defining illnesses (ADIs) among participants in a universal antiretroviral therapy program: an observational studyRisk factors for AIDS-defining illnesses among a population of poorly adherent people living with HIV/AIDS in Atlanta, Georgia.Pneumocystis pneumonia in HIV-positive patients in Spain: epidemiology and environmental risk factorsPrimer ID Informs Next-Generation Sequencing Platforms and Reveals Preexisting Drug Resistance Mutations in the HIV-1 Reverse Transcriptase Coding DomainArming of MAIT Cell Cytolytic Antimicrobial Activity Is Induced by IL-7 and Defective in HIV-1 Infection.A Remotely-Delivered CBT and Contingency Management Therapy for Substance Using People with HIVRole of the Pharmacist in Caring for Patients with HIV/AIDS: Clinical Practice Guidelines.Colonization by Pneumocystis jirovecii and its role in disease.High Mortality of Disseminated Non-Tuberculous Mycobacterial Infection in HIV-Infected Patients in the Antiretroviral Therapy Era.Predictors of opportunistic illnesses incidence in post combination antiretroviral therapy era in an urban cohort from Rio de Janeiro, Brazil.Failure to prescribe pneumocystis prophylaxis is associated with increased mortality, even in the cART era: results from the Treat Asia HIV observational databaseBurden of pneumocystis pneumonia in HIV-infected adults in sub-Saharan Africa: a systematic review and meta-analysis.Prognostic factors for severe Pneumocystis jiroveci pneumonia of non-HIV patients in intensive care unit: a bicentric retrospective studyPrevalence of and viral outcomes associated with primary HIV-1 drug resistanceImprovement in the health of HIV-infected persons in care: reducing disparities.HIV Viral Load Monitoring Frequency and Risk of Treatment Failure among Immunologically Stable HIV-Infected Patients Prescribed Combination Antiretroviral Therapy.Is primary mycobacterium avium complex prophylaxis necessary in patients with CD4 <50 cells/μL who are virologically suppressed on cART?False-Negative Results of Endoscopic Biopsy in the Diagnosis of Gastrointestinal Kaposi's Sarcoma in HIV-Infected Patients.A Matter of Perspective: Comparison of the Characteristics of Persons with HIV Infection in the United States from the HIV Outpatient Study, Medical Monitoring Project, and National HIV Surveillance System.
P2860
Q24194846-F8E4CCB9-1F0F-4E8D-B0AF-341D575E90B9Q26471480-95D49304-2E09-4FDF-9025-00B36F155FE9Q26752860-3ED64000-AABF-4BA4-AB35-84B66A856A26Q26865669-8AD63C84-263F-4E9A-9A1C-9D4503CBCE44Q27004165-D703C51C-6A15-4B7A-86E9-C5BACD43B36CQ28082149-FDF10F78-2803-4543-8DD5-D01BA8026A83Q30431684-E4F01E72-4EC6-4C80-B654-B590B9FE59D6Q30666487-A6EC130E-B864-496B-9719-EA5F2EB95C7DQ30778800-5E9BD389-4D2B-40BA-8129-0F0A4A80DD77Q30781344-70F568ED-526B-49D6-BB73-2E14EB96ED5FQ33593774-F6C13C3F-0E17-43F6-B51D-3B19EA582A6DQ33717183-78645F90-4926-432B-A9C7-F08A3463F849Q34163174-E8FE92C9-5297-41E0-A52C-799743C10DECQ34212799-0498D796-1BFE-4865-998B-7433CF0716DBQ34407741-82EF33E9-26A4-4CD2-A472-0011EEF90E42Q34475736-B4AC0957-CFD5-40F0-A1D6-7D6B4A05CD63Q34504929-7EAF539D-D67D-4713-91D7-8B83A8CE625EQ34532773-D5C51F0B-7CAB-4758-9886-082E46BFA8D1Q34633782-F01DE49C-DA81-4830-AE14-02A6DEF9AE38Q35171945-DE963373-719C-477B-B490-C071AE308437Q35193330-EC9A9D4A-77C5-40BB-956A-DF01ACE193BBQ35232696-ED0BC3D1-2DCC-4766-80C7-75A3835D5052Q35449682-A4B161B9-6888-4383-B66C-FDD180FFBD64Q35634844-AE91E0AB-6DDC-4EC0-B07C-F5454C4A4DE6Q35692184-35001AB5-38DE-4517-8C06-F041DCE10602Q35752258-452EBCCD-F299-485E-88BD-15569500E71BQ35842104-C46BE986-AB4B-4742-ABCD-645CF32C29AEQ35898538-609BAD73-67CE-4482-9E27-D6E3E0DD920EQ35940586-EF8011CF-1937-497E-904D-2859DF90301BQ35960625-8AB70B3A-F0C7-418A-9529-3B31D4E6D5B4Q35965602-3800AB76-65E4-46DD-A03F-DB740F06204BQ35967212-507E8C78-B6FC-4119-B807-5CAFFFA445DCQ36128774-66E249F1-DC98-4616-AD82-A662ED6CC0BFQ36148851-ED00CEA3-61FD-49B6-817D-6FBD54DAD70DQ36291581-B51669AA-D69A-4B9A-BB7D-4A3EEBE08B74Q36303074-9177FE98-5C9F-4267-AC41-844E55A00DF5Q36311789-0151CA1C-8159-476F-8BB9-B636F6A65504Q36311794-517DAD1F-65D5-45F0-A615-5A426DAE5742Q36443183-4EE6ACBF-97B4-411C-AD14-0CE39E131C0AQ36466550-3C7741C2-EF47-4605-AF95-922783883A2B
P2860
AIDS-defining opportunistic illnesses in US patients, 1994-2007: a cohort study.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
AIDS-defining opportunistic illnesses in US patients, 1994-2007: a cohort study.
@en
type
label
AIDS-defining opportunistic illnesses in US patients, 1994-2007: a cohort study.
@en
prefLabel
AIDS-defining opportunistic illnesses in US patients, 1994-2007: a cohort study.
@en
P2093
P1433
P1476
AIDS-defining opportunistic illnesses in US patients, 1994-2007: a cohort study.
@en
P2093
Frank J Palella
HOPS Investigators
Joan S Chmiel
John T Brooks
Kate Buchacz
Kathleen C Wood
Kenneth A Lichtenstein
Richard M Novak
Rose K Baker
P304
P356
10.1097/QAD.0B013E32833A3967
P407
P577
2010-06-01T00:00:00Z